FDA Approved: DARIFENACIN — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved the original ANDA for Darifenacin (darifenacin hydrobromide) from Cipla USA Inc., establishing a generic option for the treatment of overactive bla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Darifenacin (darifenacin)

Snippet

ORIG AP for DARIFENACIN (DARIFENACIN HYDROBROMIDE)